DOCS — Dr Martens Cashflow Statement
0.000.00%
Last trade - 00:00
- £647.34m
- £1.13bn
- £1.00bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 17.2 | 74.8 | 35.7 | 181 | 129 |
Depreciation | |||||
Non-Cash Items | 41 | 42.4 | 49.3 | 17 | 28 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -12.8 | -25.3 | 40.2 | -50.7 | -138 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 56 | 121 | 160 | 184 | 77.3 |
Capital Expenditures | -17.1 | -21.9 | -18.6 | -25 | -51.4 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0 | — | — | 0.8 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -17.1 | -21.9 | -18.6 | -25 | -50.6 |
Financing Cash Flow Items | -5.2 | -5.4 | -12.8 | -10.8 | -12 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -69.3 | -44 | -133 | -47 | -99.5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -28 | 58.8 | -3.6 | 114 | -70.5 |